These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30062975)

  • 61. A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma.
    Li X; Xu Q; Wu Y; Li J; Tang D; Han L; Fan Q
    Carcinogenesis; 2014 Jun; 35(6):1362-70. PubMed ID: 24531940
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling.
    Gu J; Wang JJ; Yan J; Cui CF; Wu WH; Li L; Wang ZS; Yu M; Gao N; Liu L; Ouyang DS
    J Ethnopharmacol; 2011 Jan; 133(1):6-13. PubMed ID: 20817083
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy and gastroparesis.
    Okamoto H; Nomura M; Nakaya Y; Uehara K; Saito K; Kimura M; Chikamori K; Ito S
    Intern Med; 2003 Aug; 42(8):655-64. PubMed ID: 12924487
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aldose reductase regulates platelet-derived growth factor-induced proliferation through mediating cell cycle progression in rat mesangial cells.
    Zou L; Wang W; Xu Z; Zhang N; Jiang T
    Int J Mol Med; 2012 Aug; 30(2):409-16. PubMed ID: 22614447
    [TBL] [Abstract][Full Text] [Related]  

  • 65. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer.
    Kavitha K; Kowshik J; Kishore TK; Baba AB; Nagini S
    Biochim Biophys Acta; 2013 Oct; 1830(10):4433-44. PubMed ID: 23726989
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG.
    Iyer S; Sam FS; DiPrimio N; Preston G; Verheijen J; Murthy K; Parton Z; Tsang H; Lao J; Morava E; Perlstein EO
    Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31636082
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epalrestat improves diabetic wound healing via increased expression of nerve growth factor.
    Nakagaki O; Miyoshi H; Sawada T; Atsumi T; Kondo T; Atsumi T
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):84-9. PubMed ID: 23426701
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Aldose Reductase Inhibitor Epalrestat Maintains Blood-Brain Barrier Integrity by Enhancing Endothelial Cell Function during Cerebral Ischemia.
    Zhang T; Wu J; Yao X; Zhang Y; Wang Y; Han Y; Wu Y; Xu Z; Lan J; Han S; Zou H; Sun Q; Wang D; Zhang J; Wang G
    Mol Neurobiol; 2023 Jul; 60(7):3741-3757. PubMed ID: 36940077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
    Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
    Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
    Yin Y; Sui C; Meng F; Ma P; Jiang Y
    Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.
    Hotta N; Akanuma Y; Kawamori R; Matsuoka K; Oka Y; Shichiri M; Toyota T; Nakashima M; Yoshimura I; Sakamoto N; Shigeta Y
    Diabetes Care; 2006 Jul; 29(7):1538-44. PubMed ID: 16801576
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells.
    Ramana KV; Friedrich B; Bhatnagar A; Srivastava SK
    FASEB J; 2003 Feb; 17(2):315-7. PubMed ID: 12490536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway.
    Raja Singh P; Sugantha Priya E; Balakrishnan S; Arunkumar R; Sharmila G; Rajalakshmi M; Arunakaran J
    Mol Cell Biochem; 2017 Mar; 427(1-2):69-79. PubMed ID: 28025797
    [TBL] [Abstract][Full Text] [Related]  

  • 75. I-123 MIBG cardiac imaging in diabetic neuropathy before and after epalrestat therapy.
    Utsunomiya K; Narabayashi I; Nakatani Y; Tamura K; Onishi S
    Clin Nucl Med; 1999 Jun; 24(6):418-20. PubMed ID: 10361937
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeted Inhibition of Hsp90 in Combination with Metformin Modulates Programmed Cell Death Pathways in A549 Lung Cancer Cells.
    Hasan A; Khamjan N; Lohani M; Mir SS
    Appl Biochem Biotechnol; 2023 Dec; 195(12):7338-7378. PubMed ID: 37000353
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ophiopogonin D modulates multiple oncogenic signaling pathways, leading to suppression of proliferation and chemosensitization of human lung cancer cells.
    Lee JH; Kim C; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
    Phytomedicine; 2018 Feb; 40():165-175. PubMed ID: 29496169
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.
    Zhen L; Fan D; Yi X; Cao X; Chen D; Wang L
    Int J Clin Exp Pathol; 2014; 7(10):6438-46. PubMed ID: 25400722
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.
    Stouffer M; Wandling E; Dickson L; Lin S; Duan H; Powe E; Jean-Louis D; Tiwari AK; Amos S
    Cancer Rep (Hoboken); 2024 May; 7(5):e2051. PubMed ID: 38702989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. LC-MS/MS method for the quantification of aldose reductase inhibitor-epalrestat and application to pharmacokinetic study.
    Nirogi R; Kandikere V; Ajjala DR; Bhyrapuneni G; Muddana NR
    J Pharm Biomed Anal; 2013 Feb; 74():227-34. PubMed ID: 23245255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.